Hence, there is a lot of interest in quantifying BDNF isoforms through a validated and reliable methodology, in order to use them as clinical and epidemiological biomarkers
doi: 10.1038/s41598-025-92868-y 74 PereiraAGEchaveJJorgeAOSNogueira-MarquesRNur YuksekEBarcielaPet al
Dipeptidyl peptidase-4 (DPP-4) inhibitors increase the bioavailability of both GLP-1 and GIP but the dogma continues to be that it is the increase in GLP-1 that contributes to the improved glucose homeostasis
Current medications: interactions are a provider-level assessment, not something a chart can capture
Given the overlap in these conditions, however, these new indications arent completely additive to sales, she added
Li J, Stein TD, Johnson JA